|
|
 |
|
Viewing report
|
|
|
|
Multiple Myeloma Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., April 2009, Pages: 493
This report analyzes the US market for Multiple Myeloma Therapeutics in Millions of US$. TThe market for multiple myeloma therapeutics is analyzed by the following Drugs: Thalomid, Revlimid, Velcade, and Others. The market for multiple myeloma therapeutics is also analyzed by the Lines of Treatment - Induction Therapy for SCT Candidates, Induction Therapy for Non-SCT Candidates, and Therapy for Relapsed or Refractory Myeloma. Annual forecasts are provided for the period of 2006 through 2015. The report profiles 98 companies including many key and niche players such as Amgen Inc., Avalon Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Kosan Biosciences, Inc., Celgene Corporation, F. Hoffmann-La Roche Ltd, Genentech, Inc., Genta Incorporated, Millennium Pharmaceuticals, Ortho Biotech Products, LP, Seattle Genetics, and Ziopharm Oncology, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Multiple Myeloma Therapeutics - US Market Trends & Analysis
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Japan
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in India
The 2010 Report on Multiple Myeloma Therapeutics: World Market Segmentation by City
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Greater China
The 2010-2015 World Outlook for Multiple Myeloma Therapeutics
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in the United States
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Africa
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Asia
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Europe
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in Oceana
The 2010-2015 Outlook for Multiple Myeloma Therapeutics in The Americas & the Caribbean
|
|
|
|
